BS, Hebrew University
MS, Graduate School of the Hebrew University
PhD, Graduate School of Tel-Aviv University
, Vanderbilt University
Biophysics and Systems Pharmacology [BSP], Cancer Biology [CAB]
Miaskiewicz K, Miller J, Ornstein R, Osman R. Molecular dynamics simulations of the effects of ring-saturated thymine lesions on DNA structure. Biopolymers 1995; 35: 113-124.
Laakkonen LJ, Guarnieri F, Perlman JH, Gershengorn MC, Osman R. A refined model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Novel mixed mode Monte Carlo/Stochastic Dynamics simulation of th. Biochemistry 1996; 35: 7651-7663.
Miaskiewicz K, Miller J, Cooney M, Osman R. Computatonal simulations of DNA distortions by a cis,syn-cyclobutance thymine dimer lesion. J Am Chem Soc 1996; 118: 9156-9163.
Laakkonen LJ, Li W, Perlman JH, Guarnieri F, Osman R, Moeller KD, Gershengorn MC. Restricted analogs provide evidence of a biologically active conformation of thyrotropin-releasing hormones. Mol Pharmacol 1996; 49: 1092-1096.
Perlman JH, Colson A-, Wang W, Bence K, Osman R, Gershengorn MC. Interactions between conserved residues in transmembrane helices 1,2, and 7 of the thyrotropin-releasing hormone receptor. J Biol Chem 1997; 272: 11937-11942.
Pasi M, Maddocks JH, Beveridge DL, Bishop TC, Case DA, Cheatham, 3rd TE, Dans PD, Jayaram B, Lankas F, Laughton C, Mitchell J, Osman R, Orozco M, Perez A, Petkeviciute D, Spackova N, Sponer J, Zakrzewska K, Lavery R. muABC: a systematic microsecond molecular dynamics study of tetranucleotide sequence effects in B-DNA.. Nucleic Acids Res 2014; 42(19): 12272-83.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Osman did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.